نتایج جستجو برای: acute gvhd

تعداد نتایج: 497927  

Journal: :Blood 2008
Tangsheng Yi Dongchang Zhao Chia-Lei Lin Chunyan Zhang Ying Chen Ivan Todorov Thomas LeBon Fouad Kandeel Stephen Forman Defu Zeng

Th17 is a newly identified T-cell lineage that secretes proinflammatory cytokine IL-17. Th17 cells have been shown to play a critical role in mediating autoimmune diseases such as EAE, colitis, and arthritis, but their role in the pathogenesis of graft-versus-host disease (GVHD) is still unknown. Here we showed that, in an acute GVHD model of C57BL/6 (H-2(b)) donor to BALB/c (H-2(d)) recipient,...

Journal: :Blood 2009
Alexander Shimabukuro-Vornhagen Michael J Hallek Rainer F Storb Michael S von Bergwelt-Baildon

Allogeneic hematopoietic stem cell transplantation is an established treatment modality for malignant and nonmalignant hematologic diseases. Acute and chronic graft-versus-host diseases (GVHDs) are a major cause of morbidity and mortality after allogeneic stem cell transplantation. T cells have been identified as key players in the graft-versus-host reaction and, therefore, most established dru...

Journal: :Journal of immunology 2001
K Nozawa J Ohata J Sakurai H Hashimoto H Miyajima H Yagita K Okumura M Azuma

We investigated the effect of CD137 costimulatory blockade in the development of murine acute and chronic graft-vs-host diseases (GVHD). The administration of anti-CD137 ligand (anti-CD137L) mAb at the time of GVHD induction ameliorated the lethality of acute GVHD, but enhanced IgE and anti-dsDNA IgG autoantibody production in chronic GVHD. The anti-CD137L mAb treatment efficiently inhibited do...

Journal: :Hematology. American Society of Hematology. Education Program 2007
Daniel Weisdorf

Acute graft-versus-host disease (GVHD) is the most frequent, morbid complication following allogeneic hematopoietic stem cell transplantation (HSCT). Its clinical toxicity, requirement for intensive immunosup-pressive management, and associated infections lead to the greatest risks of nonrelapse mortality in HSCT recipients. In acute GVHD, donor-derived T lymphocyte-mediated alloreactivity is c...

2011
Javier Briones Silvana Novelli Jorge Sierra

Acute Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic stem cell transplantation. Although this process is thought to consist of several phases, T-cell activation plays a critical role in the pathogenesis of acute GVHD. To become efficient effectors, T-cells require additional costimulation after T-cell receptor signaling. A number of molecules are involve...

2015
Michael Boyiadzis Theresa L Whiteside Steven Z Pavletic

(allo-HCT) can be curative for patients with acute leukemia [1]. The anti-leukemia activity relies on the graft-versus-leukemia (GVL) effects that are elicited after allo-HCT, suggesting that anti-tumor immunity may be responsible for eradicating leukemia and preventing subsequent relapse. However, allo-HCT is associated with significant morbidity and mortality resulting from toxicity of dose-i...

Journal: :Medicinski arhiv 2011
Svetlana Krstevska Sonja Genadieva-Stavric Aleksandra Pivkova Zlate Stojanovski Borce Georgievski Trajan Balkanov

INTRODUCTION The transplantation of hematopoietic stem cells (HSCT) is a therapeutic intervention where the hematopoietic stem cells and the cells originating from them are being removed and replaced by the normal stem cells of donor or the patient him/her-self. HSCT today represent standardized biological manipulation for treating malignant, genetic and autoimmune diseases. The application of ...

Journal: :The Tokai journal of experimental and clinical medicine 1985
R L Powles G D Goss J Millar J Maitland C Borthwick-Clark A Al-Jundi

FK506 and cyclosporine were used for the prevention of acute graft-versus-host disease. Acute GVHD was induced in Lewis rats by total-body irradiation and subsequent reconstitution with allogeneic (ACI) bone marrow and spleen cells (BMTx). GVHD was assessed by both clinical and histologic parameters during the experiment duration of 60 days, and longer for selected animals. All untreated BM rec...

2011
Daigo Hashimoto Andrew Chow Melanie Greter Yvonne Saenger Wing-Hong Kwan Marylene Leboeuf Florent Ginhoux Jordi C. Ochando Yuya Kunisaki Nico van Rooijen Chen Liu Takanori Teshima Peter S. Heeger E. Richard Stanley Paul S. Frenette Miriam Merad

Acute graft-versus-host disease (GVHD) results from the attack of host tissues by donor allogeneic T cells and is the most serious limitation of allogeneic hematopoietic cell transplantation (allo-HCT). Host antigen-presenting cells are thought to control the priming of alloreactive T cells and the induction of acute GVHD after allo-HCT. However, whereas the role of host DC in GVHD has been est...

2016
Erica Dander Paola De Lorenzo Barbara Bottazzi Paola Quarello Paola Vinci Adriana Balduzzi Francesca Masciocchi Sonia Bonanomi Claudia Cappuzzello Giulia Prunotto Fabio Pavan Fabio Pasqualini Marina Sironi Ivan Cuccovillo Roberto Leone Giovanni Salvatori Matteo Parma Elisabetta Terruzzi Fabio Pagni Franco Locatelli Alberto Mantovani Franca Fagioli Andrea Biondi Cecilia Garlanda Maria Grazia Valsecchi Attilio Rovelli Giovanna D'Amico

Acute Graft-versus-Host Disease (GvHD) remains a major complication of allogeneic haematopoietic stem cell transplantation, with a significant proportion of patients failing to respond to first-line systemic corticosteroids. Reliable biomarkers predicting disease severity and response to treatment are warranted to improve its management. Thus, we sought to determine whether pentraxin 3 (PTX3), ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید